H. Gerbaldo

673 total citations
21 papers, 407 citations indexed

About

H. Gerbaldo is a scholar working on Psychiatry and Mental health, Clinical Psychology and Endocrine and Autonomic Systems. According to data from OpenAlex, H. Gerbaldo has authored 21 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in H. Gerbaldo's work include Schizophrenia research and treatment (8 papers), Circadian rhythm and melatonin (4 papers) and Mental Health and Psychiatry (4 papers). H. Gerbaldo is often cited by papers focused on Schizophrenia research and treatment (8 papers), Circadian rhythm and melatonin (4 papers) and Mental Health and Psychiatry (4 papers). H. Gerbaldo collaborates with scholars based in Germany, United States and Argentina. H. Gerbaldo's co-authors include Konrad Maurer, Stephan Volk, L. Demisch, Michael Philipp, Klaus Georgi, Gunvant K. Thaker, Andreas Helisch, R. Kirsten, Hermann Wetzel and Marianne Moran and has published in prestigious journals such as The Lancet, Psychiatry Research and Schizophrenia Research.

In The Last Decade

H. Gerbaldo

19 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Gerbaldo Germany 10 152 146 82 57 50 21 407
Brendon Binneman United States 11 236 1.6× 142 1.0× 80 1.0× 120 2.1× 40 0.8× 17 592
Aki Kugo Japan 9 142 0.9× 155 1.1× 88 1.1× 45 0.8× 88 1.8× 11 393
Kazuto Oya Japan 11 205 1.3× 83 0.6× 66 0.8× 106 1.9× 47 0.9× 15 462
John Rotrosen United States 7 208 1.4× 57 0.4× 53 0.6× 49 0.9× 25 0.5× 8 424
Cheng‐Chen Chang Taiwan 10 144 0.9× 69 0.5× 88 1.1× 38 0.7× 27 0.5× 39 432
H.-J. Möller Germany 10 178 1.2× 35 0.2× 43 0.5× 95 1.7× 19 0.4× 26 340
Eva Kitzlerová Czechia 13 110 0.7× 137 0.9× 144 1.8× 47 0.8× 48 1.0× 28 719
Elisabetta Broggio Italy 16 150 1.0× 202 1.4× 78 1.0× 36 0.6× 60 1.2× 21 502
Osman Vırıt Türkiye 12 266 1.8× 60 0.4× 94 1.1× 77 1.4× 34 0.7× 36 677
Mariana Pedrini Brazil 16 336 2.2× 122 0.8× 180 2.2× 64 1.1× 50 1.0× 29 783

Countries citing papers authored by H. Gerbaldo

Since Specialization
Citations

This map shows the geographic impact of H. Gerbaldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gerbaldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gerbaldo more than expected).

Fields of papers citing papers by H. Gerbaldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gerbaldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gerbaldo. The network helps show where H. Gerbaldo may publish in the future.

Co-authorship network of co-authors of H. Gerbaldo

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gerbaldo. A scholar is included among the top collaborators of H. Gerbaldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gerbaldo. H. Gerbaldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maurer, Konrad, Stephan Volk, & H. Gerbaldo. (1997). Auguste D and Alzheimer's disease. The Lancet. 349(9064). 1546–1549. 227 indexed citations
2.
Maurer, K., Susan W. Volk, & H. Gerbaldo. (1997). Auguste D. première patiente du docteur Alzheimer : Des archives retrouvées par hasard révèlent les symptômes de la malade : Alzheimer la maladie du siècle. 58–60.
3.
Gerbaldo, H., et al.. (1997). The assessment of light intensity preference in psychiatric patients: a questionnaire. Acta Psychiatrica Scandinavica. 95(3). 236–241. 12 indexed citations
4.
Gerbaldo, H. & F. Müller-Siecheneder. (1996). Über die Bedeutung der primären Negativsymptomatik bei schizophrenen und anderen psychiatrischen Patienten. Fortschritte der Neurologie · Psychiatrie. 64(6). 221–227. 2 indexed citations
5.
Gerbaldo, H., et al.. (1995). Primary enduring negative symptoms in schizophrenia and major depression. Journal of Psychiatric Research. 29(4). 297–302. 19 indexed citations
6.
Gerbaldo, H. & Michael Philipp. (1995). The Deficit Syndrome in Schizophrenic and Nonschizophrenic Patients: Preliminary Studies. Psychopathology. 28(1). 55–63. 11 indexed citations
7.
Gerbaldo, H., Andreas Helisch, Barbara Schneider, Michael Philipp, & Otto Benkert. (1994). Subtypes of negative symptoms: The primary subtype in schizophrenic and non-schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 18(2). 311–320. 12 indexed citations
8.
Benkert, Otto, H. Gerbaldo, & Hermann Wetzel. (1993). Negative symptomatology: psychopharmacological strategies and methodological aspects for drug evaluation. European Neuropsychopharmacology. 3(3). 204–205. 2 indexed citations
9.
Gerbaldo, H., L. Demisch, & Daniel P. Cardinali. (1992). Light exposure patterns in schizophrenia. Acta Psychiatrica Scandinavica. 85(1). 94–95. 5 indexed citations
10.
Gerbaldo, H., et al.. (1992). Abnormal Electroretinography in Schizophrenic Patients with a History of Sun Gazing. Neuropsychobiology. 25(2). 99–101. 21 indexed citations
11.
12.
Gerbaldo, H., et al.. (1992). SUBTYPES OF NEGATIVE SYNDROMS. Clinical Neuropharmacology. 15. 255B–255B. 1 indexed citations
13.
Gerbaldo, H. & Gunvant K. Thaker. (1991). Photophilic and Photophobic Behaviour in Patients with Schizophrenia and Depression. The Canadian Journal of Psychiatry. 36(9). 677–679. 7 indexed citations
14.
Gerbaldo, H., et al.. (1990). Self-Reports in Chronic Schizophrenic Patients with Primary Negative Symptoms: Preliminary Results. Pharmacopsychiatry. 23(4). 195–197. 3 indexed citations
15.
Gerbaldo, H., et al.. (1990). Photophobic and photomanic behavior in psychoses. Schizophrenia Research. 3(1). 74–75. 2 indexed citations
16.
17.
Demisch, L., et al.. (1988). Fluvoxamine-Melatonin-Stimulation-Test (FMST) in Patients with Depressive Disorders. Pharmacopsychiatry. 21(6). 420–421. 4 indexed citations
18.
Gerbaldo, H., et al.. (1988). The Effect of OPC-4392, a Partial Dopamine Receptor Agonist on Negative Symptoms: Results of an Open Study. Pharmacopsychiatry. 21(6). 387–388. 12 indexed citations
19.
Demisch, L., et al.. (1987). Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophreniform or schizophrenic disorders. Psychiatry Research. 22(4). 275–282. 26 indexed citations
20.
Vila, Santiago, et al.. (1987). Possible relationship between pervasive developmental disorders and platelet monoamine oxidase activity.. PubMed. 20(2). 161–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brendon Binneman Breakdown of academic impact, for papers by Aki Kugo Breakdown of academic impact, for papers by Kazuto Oya Breakdown of academic impact, for papers by John Rotrosen Breakdown of academic impact, for papers by Cheng‐Chen Chang Breakdown of academic impact, for papers by H.-J. Möller Breakdown of academic impact, for papers by Eva Kitzlerová Breakdown of academic impact, for papers by Elisabetta Broggio Breakdown of academic impact, for papers by Osman Vırıt Breakdown of academic impact, for papers by Mariana Pedrini
Rankless by CCL
2026